Risk factor [qnco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Drug [phsu]    
Resistance [ftcn]    
Hepatitis B, Chronic [dsyn]    
Aim [idcn]    
To [qlco]    
investigate [ftcn]    
Risk factor [qnco]    
Characteristic [qlco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Drug [phsu]    
Resistance [ftcn]    
Hepatitis B, Chronic [dsyn]    
Method [inpr]    
% total [qnco]    
patient [podg]    
Drug [phsu]    
Resistance [ftcn]    
Hepatitis B, Chronic [dsyn]    
Analyzed [resa]    
patient [podg]    
Divide [ftcn]    
Two [qnco]    
Group [idcn]    
Hepatocellular carcinoma [neop]    
Group [idcn]    
Non [ftcn]    
Hepatocellular carcinoma [neop]    
Group [idcn]    
Two [qnco]    
Group [idcn]    
Compare [acty]    
Using [ftcn]    
Logistic Regression [resa]    
Various [irda]    
patient [podg]    
Viral [ftcn]    
Characteristic [qlco]    
Order [inpr]    
Associated [qlco]    
Risk factor [qnco]    
Hepatocellular carcinoma [neop]    
*^patient [podg]    
Tumor [neop]    
Characteristic [qlco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Hepatitis B, Chronic [dsyn]    
Group [idcn]    
Compare [acty]    
Hepatocellular carcinoma [neop]    
Group [idcn]    
R- [spco]    
Group [idcn]    
To [qlco]    
*Difference [qnco]    
Hepatocellular carcinoma [neop]    
Characteristic [qlco]    
Result [ftcn]    
Significance [qnco]    
*Difference [qnco]    
Found [qnco]    
Age [orga]    
Platelet Count [lbpr]    
Positive [qnco]    
Hbe Ag [imft]    
Rate [acty]    
Hbe Ag [imft]    
virologic [ftcn]    
Response [orga]    
Child-Pugh Score [inpr]    
Presence [topp]    
Duration [tmco]    
Antiviral [phsu]    
treatment [ftcn]    
Non [ftcn]    
Hepatocellular carcinoma [neop]    
Hepatocellular carcinoma [neop]    
Group [idcn]    
Cirrhosis [dsyn]    
Age [orga]    
year [tmco]    
Hbe Ag [imft]    
virologic [ftcn]    
Non [ftcn]    
Status [qlco]    
Mutant [comd]    
Independence [idcn]    
Risk factor [qnco]    
development [phsf]    
Hepatocellular carcinoma [neop]    
R- [spco]    
Group [idcn]    
Lower [spco]    
Serum [bdsu]    
alpha fetoprotein levels [lbtr]    
Early [tmco]    
Stage [tmco]    
Tumor [neop]    
short period [fndg]    
Mean [qnco]    
Tumor [neop]    
surveillance [ftcn]    
Group [idcn]    
% total [qnco]    
Follow-up [fndg]    
Duration [tmco]    
Not [ftcn]    
Different [qlco]    
Two [qnco]    
Group [idcn]    
Conclusion [idcn]    
patient [podg]    
Drug [phsu]    
Resistance [ftcn]    
Hepatitis B, Chronic [dsyn]    
Hepatocellular carcinoma [neop]    
Age [orga]    
Cirrhosis [dsyn]    
Status [qlco]    
Hbe Ag [imft]    
Status [qlco]    
virologic [ftcn]    
Response [orga]    
Associated [qlco]    
Risk [qlco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Drug [phsu]    
Resistance [ftcn]    
Hepatitis B, Chronic [dsyn]    
Clinical [qlco]    
Factor [ftcn]    
Benefit [qnco]    
Hepatocellular carcinoma [neop]    
surveillance [ftcn]    
[c] [qnco]    
Rights [qlco]    
Reservation [acty]    
